With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro. With a ...
Cancer patients and their care teams are taking center stage in Amgen's newest online campaign. The Neulasta Onpro effort, dubbed Neulasta Onpro Narratives, highlights patients’ and professionals’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback